| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5687441 | The Journal of Urology | 2017 | 32 Pages |
Abstract
Analyzing hematuria patients for the risk of bladder cancer using novel molecular markers may lead to a reduction in diagnostic cystoscopy. Combining methylation analysis (OTX1, ONECUT2 and TWIST1) with mutation analysis (FGFR3, TERT and HRAS) and patient age resulted in a validated accurate prediction model.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel-van der Made, Kirstin A. van der Keur, Joost L. Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F. Ãrntoft, Francisco X. Real, Ulrika Segersten, Núria Malats, Per-Uno Malmström,